David Pollock, Ph.D., and Jennifer Pollock, Ph.D., will direct the new Translational Cardio-Renal Research section in Nephrology starting in early 2014.
Researchers found differences in polymerase chains thought to be similar, potentially opening new pathways toward cancer drug development.
As part of the award, Peter Anderson, D.V.M., Ph.D., director of Pathology Undergraduate Education, will lead faculty development programs and hands-on workshops at the Tzu-Chi University College of Medicine in Taiwan for two weeks.
Molecular events that form such “reward memories” appear to differ from those created by drug addiction, despite the popular theory that addiction hijacks normal reward pathways.
Discovery leads researchers to redouble efforts to design a new class of drugs to treat diabetes.
Researchers show long-term efficacy of the first FDA approved drug for vasculitis.
The new Viral Hepatitis Clinic offers patients the latest therapies and follows the treatment model in HIV care pioneered by the 1917 Clinic.
Originally built in 1975, the Wallace Tumor Institute is the hub of the Comprehensive Cancer Center’s research and administrative enterprise.
Klaus Mönkemüller, M.D., Ph.D., FASGE, has been elected co-chair of the International Committee of the American Society of Gastrointestinal Endoscopy.
Jane Schwebke, M.D., has been honored for high achievement in research and prevention by the American Sexually Transmitted Diseases Association.